Stay updated on Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.

Latest updates to the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page
- Check7 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check14 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check36 days agoChange DetectedThe website has updated the intervention details to include a verified status from the Institute of Hematology & Blood Diseases Hospital, China, indicating it is currently recruiting, while the previous type of intervention has been removed.SummaryDifference4%
- Check65 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check72 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.